Learning objectives

▪To review the normal bleeding cessation and clot formation process.

▪To understand the differential diagnosis of bleeding disorder by abnormality in PT/PTT studies.

▪To familiarize with typical presenting symptoms and treatment of bleeding in patients with Hemophilia and von Willebrand disease (vWD).

▪To appreciate how inhibitor development complicates treatment in patients with hemophilia and how to treat acute bleeds in this population.

▪To appropriately recommend disposition by bleed type.

Charise Freundlich, Presenter, has no relevant financial relationships to disclose.